Attached files
file | filename |
---|---|
EX-31.A - EX-31.A - DUSA PHARMACEUTICALS INC | y90065exv31wa.htm |
EX-32.B - EX-32.B - DUSA PHARMACEUTICALS INC | y90065exv32wb.htm |
EX-99.1 - EX-99.1 - DUSA PHARMACEUTICALS INC | y90065exv99w1.htm |
EX-32.A - EX-32.A - DUSA PHARMACEUTICALS INC | y90065exv32wa.htm |
EX-21.A - EX-21.A - DUSA PHARMACEUTICALS INC | y90065exv21wa.htm |
EX-23.A - EX-23.A - DUSA PHARMACEUTICALS INC | y90065exv23wa.htm |
10-K - FORM 10-K - DUSA PHARMACEUTICALS INC | y90065e10vk.htm |
EXHIBIT 31(b)
DUSA
PHARMACEUTICALS, INC.
CERTIFICATIONS
CERTIFICATIONS
I, Richard C. Christopher, certify that:
1. I have reviewed this annual report on
Form 10-K
of DUSA Pharmaceuticals, Inc.;
2. Based on my knowledge, this report does not contain any
untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the
circumstances under which such statements were made, not
misleading with respect to the period covered by this report;
3. Based on my knowledge, the financial statements, and
other financial information included in this report, fairly
present in all material respects the financial condition,
results of operations and cash flows of the registrant as of,
and for, the periods presented in this report;
4. The registrants other certifying officer and I are
responsible for establishing and maintaining disclosure controls
and procedures (as defined in Exchange Act
Rules 13a-15(e)
and
15d-15(e))
and internal control over financial reporting (as defined in
Exchange Act
Rules 13a-15(f)
and
15d-15(f))
for the registrant and have:
a) Designed such disclosure controls and procedures, or
caused such disclosure controls and procedures to be designed
under our supervision, to ensure that material information
relating to the registrant, including its consolidated
subsidiary, is made known to us by others within those entities,
particularly during the period in which this report is being
prepared;
b) Designed such internal control over financial reporting,
or caused such internal control over financial reporting to be
designed under our supervision, to provide reasonable assurance
regarding the reliability of financial reporting and the
preparation of financial statements for external purposes in
accordance with generally accepted accounting principles;
c) Evaluated the effectiveness of the registrants
disclosure controls and procedures and presented in this report
our conclusions about the effectiveness of the disclosure
controls and procedures, as of the end of the period covered by
this report based on such evaluation; and
d) Disclosed in this report any change in the
registrants internal control over financial reporting that
occurred during the registrants most recent fiscal quarter
(the registrants fourth fiscal quarter in the case of an
annual report) that materially affected, or is reasonably likely
to materially affect, the registrants internal control
over financial reporting; and
5. The registrants other certifying officer and I
have disclosed, based on our most recent evaluation of internal
control over financial reporting, to the registrants
auditors and the audit committee of the registrants board
of directors (or persons performing the equivalent functions):
a) All significant deficiencies and material weaknesses in
the design or operation of internal control over financial
reporting which are reasonably likely to adversely affect the
registrants ability to record, process, summarize and
report financial information; and
b) Any fraud, whether or not material, that involves
management or other employees who have a significant b role in
the registrants internal control over financial reporting.
Dated: March 3, 2011
|
/s/ Richard
C.
Christopher Richard
C. ChristopherVice President, Finance and Chief Financial Officer (principal financial officer) |